Plasmapp Co., Ltd.: debt-to-equity, ROE and more
KOSDAQ, Legal name Plasmapp Co., Ltd.
Latest figures are the FY2025 consolidated summary statements.
Latest fiscal year ratios (computed here)
- Debt/equity
- 259.3%
- Equity ratio
- 27.8%
- ROE
- -115.2%
- Op. margin
- -89.6%
- Rev. growth
- -16.3%
- Interest coverage
- n/a
Condition flags
- Latest operating profit is not above zero, or not reported.
- Operating loss for 4 straight years.
- Total equity is above paid-in capital. Not capital-impaired.
Interest coverage and dividends (OpenDART)
Interest expense and dividends come from DART's OpenDART annual-report filings, not the FSC summary statements used above. The source differs from the other tables on this page.
Interest coverage = operating profit ÷ interest expenseNo interest expense value yet for this company. Most companies fold interest expense into a single finance-costs line on their income statement, so it cannot be pulled out separately. Interest coverage is not computed here.
Dividends, last 3 fiscal years
No dividend data yet for this company.
Source values from the OpenDART (금융감독원 전자공시) annual report. Report fiscal year 2025.
Ratios by year (computed here)
Debt-to-equity = total liabilities ÷ total equity × 100Equity ratio = total equity ÷ total assets × 100ROE = net income ÷ year-end total equity × 100Operating margin = operating profit ÷ revenue × 100Revenue growth = (this year − last year) ÷ last year × 100
Computed from the source figures above with these formulas. Where the source's own debt-to-equity differs from ours, both are shown for that year.
| Fiscal year | Debt/equity | Equity ratio | ROE | Op. margin | Rev. growth |
|---|---|---|---|---|---|
| FY2022 consolidated | 286.9% | 25.8% | -188.7% | -130.4% | n/a |
| FY2023 consolidated | 392.5% | 20.3% | -232.6% | -159.3% | -2.9% |
| FY2024 consolidated | 463.6% | 17.7% | -459.1% | -174.2% | -21.5% |
| FY2025 consolidated | 259.3% | 27.8% | -115.2% | -89.6% | -16.3% |
Source figures (FSC summary statements)
Amounts are the source values, shortened. A cell reported as zero may be blank in the source, so it is not used in any ratio.
| Fiscal year | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue | ₩13.3B | ₩12.9B | ₩10.1B | ₩8.5B |
| Operating profit | -₩17.4B | -₩20.6B | -₩17.7B | -₩7.6B |
| Pre-tax income | -₩17.7B | -₩18.8B | -₩20.8B | -₩6.6B |
| Net income | -₩17.7B | -₩18.8B | -₩20.8B | -₩6.6B |
| Total assets | ₩36.3B | ₩39.8B | ₩25.5B | ₩20.6B |
| Total liabilities | ₩26.9B | ₩31.7B | ₩21.0B | ₩14.8B |
| Total equity | ₩9.4B | ₩8.1B | ₩4.5B | ₩5.7B |
| Paid-in capital | ₩8.9B | ₩10.1B | ₩13.0B | ₩1.9B |
| Debt/equity (source value) | 286.9% | 392.5% | 463.6% | 259.3% |
Company outline (FSC)
- Market
- KOSDAQ
- Fiscal year end
- Dec
- Founded
- 2015-03-31
- Listed
- 22/10/21
- Employees
- 46
- Auditor
- 삼정
- Audit opinion
- 적정의견
- Corporate reg. no.
- 1601110395297
- Outline updated
- 2026-09-24
Check the original filings
Read the annual report and audit report before you decide anything. The link opens a DART search for this company's name.
Search DART for 플라즈맵Computed from the Financial Services Commission's company outline and summary statements (data.go.kr). Data as of 2026-09-24.